Records containing: Systemic Lupus Erythematosus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-11-25Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches (The ABC Study)
-
CLINICAL_TRIALS study record update · 2020-11-23Determining the Association Between Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
-
CLINICAL_TRIALS study record update · 2020-10-09Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis
-
CLINICAL_TRIALS study record update · 2020-10-08Highly Sensitive Serum Cardiac Troponin T and Cardiovascular Events in Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2020-09-25Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-09-22Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases
-
CLINICAL_TRIALS study record update · 2020-09-17A Randomised, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2020-09-04The Biodistribution of 18F-Clofarabine in Patients With Autoimmune and Inflammatory Diseases
-
CLINICAL_TRIALS study record update · 2020-08-27A Cross-Sectional Study of Cell Surface Marker Expression in Participants With Autoimmune or Inflammatory Diseases
-
CLINICAL_TRIALS study record update · 2020-08-17An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2020-08-04Evaluation of Clinical Performance of Serologic Anti-Ro60 Autoantibody Detection Kit on BioCLIA Platform
-
CLINICAL_TRIALS study record update · 2020-07-29Validation of the Assay of Circulating Antibodies Against Glomerular Neo-autoantigens as a Surrogate Biomarker of the Development of Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2020-07-21Regulatory B Cells in Inflammatory Rheumatisms, Systemic Auto-immune Diseases in Adults and Biomarkers of Response to Biologic Treatments
-
CLINICAL_TRIALS study record update · 2020-07-07A Phase II, Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of GDC-0853 in Patients With Moderate to Severe Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2020-05-22Care Coordination Approaches to Learning Lupus Self-management
-
CLINICAL_TRIALS study record update · 2020-04-28The Safety and Efficacy of the Traditional Chinese Medicine Zishenqing in Subjects With Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2020-04-21Telangiectatic Palmoplantar Keratoderma in Systemic and Subacute Lupus Erythematosus : to a Form of Lichen Planus-like Lupus Erythematosus ?
-
CLINICAL_TRIALS study record update · 2020-03-26A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNα-Kinoid in Adult Subjects With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2020-03-19A Pilot, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Study To Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of CC-220 In Subjects With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2020-03-19The Effect of BMS-986165 on the Pharmacokinetics of a Combined Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Subjects
-
CLINICAL_TRIALS study record update · 2020-03-04Evaluation of Janus Kinase_3 Expression in Juvenile Onset Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2020-03-04A Phase IIb , Placebo-Controlled ,Multi-Center, Randomized, Double-Blind, Dose-explorating Trial of RC18,a Recombinant Human B Lymphocyte Stimulating Factor Receptor-Antibody Fusion Protein in Subjects With Systemic Lupus Erythematosus (SLE).
-
CLINICAL_TRIALS study record update · 2020-02-28Cyclophosphamide and rATG/Rituximab in Patients With Systemic Lupus Erythematosus: Phase II Trial
-
CLINICAL_TRIALS study record update · 2020-02-26A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-response Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2020-02-25A Phase 1, Randomized, Open-Label, Single-Dose, Crossover Study To Evaluate the Bioavailability of BMS-986165 Tablet Formulation Relative To BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal And Increased Gastric pH on the Bioavailability of BMS-986165 Tablet Formulation in Healthy Subjects